Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer?

Autor: Goldberg H; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and the University of Toronto, Toronto, ON, Canada.; Department of Urology, SUNY Upstate Medical University, Syracuse, NY, USA., Glicksman R; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada., Woon D; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and the University of Toronto, Toronto, ON, Canada., Hoffman A; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and the University of Toronto, Toronto, ON, Canada., Shaikh H; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and the University of Toronto, Toronto, ON, Canada., Chandrasekar T; Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Klaassen Z; Division of Urology, Department of Surgery, Medical College of Georgia, Augusta University, Augusta, GA, USA.; Georgia Cancer Center, Augusta, GA, USA., Wallis CJD; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and the University of Toronto, Toronto, ON, Canada., Ahmad AE; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and the University of Toronto, Toronto, ON, Canada., Sanmamed-Salgado N; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada., Qu X; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada., Moraes FY; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada., Diamandis EP; Department of Pathology and Laboratory Medicine, Sinai Health System, University of Toronto, Toronto, ON, Canada., Berlin A; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Techna Institute, University Health Network, Toronto, ON, Canada., Fleshner NE; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and the University of Toronto, Toronto, ON, Canada.

Publikováno v: BJU international [BJU Int] 2021 Jun; Vol. 127 (6), pp. 654-664. Date of Electronic Publication: 2020 Sep 26.

Utility of digital rectal examination in a population with prostate cancer treated with active surveillance.

Autor: Herrera-Caceres JO; Division of Urology, Department of Surgical Oncology, University of Toronto and University Health Network, Toronto, ON, Canada., Wettstein MS; Division of Urology, Department of Surgical Oncology, University of Toronto and University Health Network, Toronto, ON, Canada., Goldberg H; Division of Urology, Department of Surgical Oncology, University of Toronto and University Health Network, Toronto, ON, Canada., Toi A; Department of Medical Imaging, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Chandrasekar T; Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, United States., Woon DTS; Division of Urology, Department of Surgical Oncology, University of Toronto and University Health Network, Toronto, ON, Canada., Ahmad AE; Division of Urology, Department of Surgical Oncology, University of Toronto and University Health Network, Toronto, ON, Canada., Sanmamed-Salgado N; Department of Radiation Oncology, University of Toronto and University Health Network, Toronto, ON, Canada., Alhunaidi O; Division of Urology, Department of Surgical Oncology, University of Toronto and University Health Network, Toronto, ON, Canada., Ajib K; Division of Urology, Department of Surgical Oncology, University of Toronto and University Health Network, Toronto, ON, Canada., Nason G; Division of Urology, Department of Surgical Oncology, University of Toronto and University Health Network, Toronto, ON, Canada., Tan GH; Division of Urology, Department of Surgical Oncology, University of Toronto and University Health Network, Toronto, ON, Canada., Fleshner N; Division of Urology, Department of Surgical Oncology, University of Toronto and University Health Network, Toronto, ON, Canada., Klotz L; Division of Urology, Department of Surgery, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

Publikováno v: Canadian Urological Association journal = Journal de l'Association des urologues du Canada [Can Urol Assoc J] 2020 Sep; Vol. 14 (9), pp. E453-E457.

Enalapril y secreción inadecuada de hormona antidiurética

Autor: Prieto de Paula, J.M. ^{a, ⁎}, Sanmamed Salgado, N. ^{a, b}, Pérez Fernández, C. ^a, Escudero Piñeiro, C.G. ^a, Franco Hidalgo, S. ^b

Publikováno v: In SEMERGEN - Medicina de Familia October 2013 39(7):400-401

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[Situs ambiguous or heterotaxy].

Autor: López Pedreira R; Servicio de Radiodiagnóstico, Hospital Clínico Universitario de Valladolid, Valladolid, España., Cartón Sánchez P, Sanmamed Salgado N, Prieto de Paula JM

Publikováno v: Medicina clinica [Med Clin (Barc)] 2013 Oct 19; Vol. 141 (8), pp. 370. Date of Electronic Publication: 2013 May 13.